11 hrs ago | MediLexicon
Four-type HPV Vaccine Gardasil(R) Is Also Effective In Men
The four-type human papillomavirus vaccine Gardasil is also effective in men according to the primary analysis from a pivotal phase III clinical study.
19 hrs ago | MediLexicon
Hologic Releases The Results Of The Cervista(TM) HPV Clinical Trials
Main Category: Cervical Cancer / HPV Vaccine Also Included In: Clinical Trials / Drug Trials Article Date: 14 Nov 2008 Hologic, Inc.
Dr. Harold Freeman began his medical practice in Harlem, New York in 1967, and was surprised to find out that many if not most of the patients he saw with cancer had advanced disease.
Researchers Say Identification of Women With HPV Types 16, 18 and 45...
Researchers Say Identification of Women With HPV Types 16, 18 and 45 Could Improve Early Intervention to Stop Cervical Cancer 07:00 Xinhua PR Newswire Results Presented for Genotyping Tests Now Under ...
New Research Shows Knowledge Of HPV And Vaccination Could Improve Cervical Screening Attendance
Main Category: Cervical Cancer / HPV Vaccine Also Included In: Immune System / Vaccines Article Date: 17 Nov 2008 Information about vaccination against the virus that causes cervical cancer could encourage ...
Aussie vaccine wins medical Nobel Prize
The Australian-pioneered cervical cancer vaccine, Gardasil, has been awarded the drug industry equivalent of a Nobel Prize.
Gardasil for males? Report hikes hopes
Will yesterday's news that Merck's Gardasil vaccine may protect men, as well as women, from a deadly virus bolster sales of a product that so far has failed to fulfill its maker's hopes for a blockbuster? In ...
Experts Jointly Hunt For Cancer Clues
A 2.7m pound research centre will search out the earliest signs of cancer - " in the hope of giving patients the best possible chance of beating the disease.
Australian Broadcasting Corporation
Frazer to unveil skin cancer vaccine
Professor Frazer will outline his latest skin cancer breakthrough tomorrow. ) Map: Brisbane 4000 Human trials of a world-first skin cancer vaccine could start as early as next year.
Africa: Cervical Cancer Strikes Poor Women Hardest
Miriam Mannak Cape Town Of the 490,000 women worldwide who are diagnosed with cervical cancer each year, 80 percent live in the developing world.
Cowen accuses Kenny of 'emotional blackmail' over vaccine
Cervical cancer screening provides better cover than a vaccination programme, Taoiseach Brian Cowen claimed today in the Dail.
Identifying Women With HPV Improves Early Intervention
As testing for high-risk types of the human papillomavirus emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely ...
06:39 Dublin protests over plans to scrap cervical cancer vaccine
A rally is to take place in Dublin today against the Minister for Health's plans to scrap the cervical cancer vaccine for young girls.
Arbor Vita Presents New Data on Cancer Diagnostic at EUrogin
Arbor Vita Corporation , a privately held biopharmaceutical company, presented new data today on its rapid, point-of-care prototype HPV test with a high positive predictive value for cervical cancer and ...
McDaid unrepentant after cancer vaccine vote
Donegal TD Jim McDaid says he would have voted against the Government in this week's Dail vote on the cervical cancer vaccination programme if such a move would have reversed Mary Harney's decision to scrap the ...
Tanaiste 'disappointed' at Government poll slump
Tanaiste Mary Coughlan has admitted that the latest Irish Times /TNS mrbi poll, which shows support for the Government plummeting, is extremely "disappointing" but has pledged to continue with efforts to rescue ...
'Women Against Cervical Cancer' - A New International Network...
Main Category: Cervical Cancer / HPV Vaccine Article Date: 12 Nov 2008 - 2:00 PST New survey results announced today, reveal a significant lack of information and education about the prevention, treatment and ...
Merck Frosst Canada Ltd. Release: HPV Vaccine Prevents Genital Warts...
GARDASILA [Human Papillomavirus Quadrivalent Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus types 6, ...